Rosuvastatin Calcium/Gemigliptin L-tartrate Sesquihydrate

็‘ž่ˆ’ไผไป–ๆฑ€้’™/ๅ‰ๆ ผๅˆ—ๆฑ€้…’็Ÿณ้…ธ็›

Report date: 2026/02/02 17:59:15

Base Information

Drug NameRosuvastatin Calcium/Gemigliptin L-tartrate Sesquihydrate
Drug Alias Nameๅ‰ๆ ผๅˆ—ๆฑ€้…’็Ÿณ้…ธ็›/็‘ž่ˆ’ไผไป–ๆฑ€้’™Rosuvastatin/gemigliptinGemigliptin/rosuvastatinZemiStatin
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IVHMG-CoA reductase
Therapy Area/IndicationsDyslipidemiasDiabetes Mellitus, Type 2
Global Approved IndicationsDyslipidemiasDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2017/07/31
Country/TerritorySouth Korea
CombinationsYes Gemigliptin L-tartrate SesquihydrateRosuvastatin Calcium
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical Ltd
Inactive CompaniesN/A
Active IndicationsDyslipidemiasDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A